Market Place
Sourcing Support
All News #Library
Biotech
Dermata Opens A New Chapter With The Release Of Tome Skincare
05 Mar 2026 //
PHARMIWEB
Dermata Therapeutics Presents Abstract at EADV Congress 2025
17 Sep 2025 //
PHARMAWEB
Dermata Gets Australian Patent for Hyperhidrosis Treatment
08 Jul 2025 //
ACCESSWIRE
Dermata Therapeutics Updates on Q1 2025 Financial Results
14 May 2025 //
ACCESSWIRE
Dermata`s XYNGARI™ Phase 3 Trial Meets Primary Endpoints
27 Mar 2025 //
PR NEWSWIRE
Dermata Therapeutics Exercises Warrants for $6.2M on Nasdaq Rules
27 Mar 2025 //
ACCESSWIRE
Dermata Therapeutics Updates on 2024 Financial Results
17 Mar 2025 //
ACCESSWIRE
Dermata Receives Notice of Allowance for DMT310 Acne Patent
10 Dec 2024 //
ACCESSWIRE
Dermata Completes DMT310 Phase 3 Enrollment for Acne
03 Dec 2024 //
ACCESSWIRE
Dermata Therapeutics Closes $3.5 Million Private Placement Priced At-The-Market
17 Sep 2024 //
ACCESSWIRE
Dermata Therapeutics Announces $3.5 Million Private Placement
16 Sep 2024 //
ACCESSWIRE
Dermata To Participate In H.C. Wainwright Conference
05 Sep 2024 //
ACCESSWIRE
Dermata Therapeutics Reports Q2 2024 Results And Corporate Update
07 Aug 2024 //
ACCESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.